<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Galloway Henriksen | Activity</title>
	<link>https://recash.wpsoul.net/members/atticnode1/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/atticnode1/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Galloway Henriksen.</description>
	<lastBuildDate>Wed, 05 Aug 2026 23:09:15 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">39b33975c8c60685d3e3064839185f01</guid>
				<title>Galloway Henriksen posted an update: Objectives The objective of the present work to encapsulate [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/159666/</link>
				<pubDate>Thu, 09 Jan 2025 10:48:08 +0000</pubDate>

									<content:encoded><![CDATA[<p>Objectives The objective of the present work to encapsulate the resveratrol (RES) inside the chitosan-based microsponges, employing the systematic optimization by 33 Box-Behnken design for the colonic targeting.Significance Enhanced therapeutic efficacy of RES-loaded microsponges and matrix tablets, vis-a-vis pureRES for ulcerative colitis.Methods&hellip;<span class="activity-read-more" id="activity-read-more-159666"><a href="https://recash.wpsoul.net/activity/p/159666/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a0f347cf4a41583d341a9820ae6a9ae9</guid>
				<title>Galloway Henriksen posted an update: Rationale &#038; aim Various types of cell therapies are currently [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/156947/</link>
				<pubDate>Wed, 08 Jan 2025 10:25:19 +0000</pubDate>

									<content:encoded><![CDATA[<p>Rationale &amp; aim Various types of cell therapies are currently under investigation for the treatment of ischemic stroke patients. To bridge the gap between cell administration and therapeutic outcome, there is a need for non-invasive monitoring of these innovative therapeutic approaches. Spectral photon counting computed tomography (SPCCT) is a new&hellip;<span class="activity-read-more" id="activity-read-more-156947"><a href="https://recash.wpsoul.net/activity/p/156947/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a8f8df3d280304d50195c713241bec01</guid>
				<title>Galloway Henriksen posted an update: On laparoscopy, the rectum was dissected posterolaterally, [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/151108/</link>
				<pubDate>Mon, 06 Jan 2025 10:46:19 +0000</pubDate>

									<content:encoded><![CDATA[<p>On laparoscopy, the rectum was dissected posterolaterally, and a defect was identified in the right anterior sacrococcygeal region through which part of the rectum protruded. This was followed by the placement of a self-gripping polyester mesh via a sacrococcygeal approach. There were no postoperative complications. The patient was discharged on&hellip;<span class="activity-read-more" id="activity-read-more-151108"><a href="https://recash.wpsoul.net/activity/p/151108/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c72e35e8ee189058b2b3b0b2d62c4a3f</guid>
				<title>Galloway Henriksen became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/146054/</link>
				<pubDate>Sun, 05 Jan 2025 13:39:38 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>